← FDA DRUG APPROVALS

FDA NDA · NDA018258

DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER

Sponsor: B BRAUN

APPLICATION
NDA018258
TYPE
NDA
ORIGINAL APPROVAL
1980-04-17
LATEST ACTION
1990-09-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINERDiscontinued
CALCIUM CHLORIDE 20MG/100ML, DEXTROSE 5GM/100ML, POTASSIUM CHLORIDE 30MG/100ML, SODIUM ACETATE 380MG/100ML, SODIUM CHLORIDE 600MG/100ML · INJECTABLE · INJECTION

Approval history

1990-09-11Manufacturing (CMC) · Supplement 13 · standardAP
1986-02-18Manufacturing (CMC) · Supplement 7 · standardAP
1985-06-28Manufacturing (CMC) · Supplement 8 · standardAP
1985-06-25Labeling · Supplement 11 · standardAP
1985-04-03Manufacturing (CMC) · Supplement 10 · standardAP
1983-01-24Labeling · Supplement 5 · standardAP
1981-10-26Manufacturing (CMC) · Supplement 6 · standardAP
1980-10-24Manufacturing (CMC) · Supplement 4 · standardAP
1980-08-06Manufacturing (CMC) · Supplement 3 · standardAP
1980-06-18Manufacturing (CMC) · Supplement 2 · standardAP
1980-06-09Manufacturing (CMC) · Supplement 1 · standardAP
1980-04-17Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →